[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*3501).
DOI=10.1007/BF02421534; PubMed=2788131 [NCBI, ExPASy, EBI, Israel, Japan]
Ooba T.,
Hayashi H.,
Karaki S.,
Tanabe M.,
Kano K.,
Takiguchi M.;
"The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.";
Immunogenetics 30:76-80(1989).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*3502).
DOI=10.1016/0198-8859(91)90020-A; PubMed=1890016 [NCBI, ExPASy, EBI, Israel, Japan]
Chertkoff L.P.,
Herrera M.,
Fainboim L.,
Satz M.L.;
"Complete nucleotide sequence of a genomic clone encoding HLA-B35 isolated from a Caucasian individual of Hispanic origin. Identification of a new variant of HLA-B35.";
Hum. Immunol. 31:153-158(1991).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*3503).
PubMed=1541831 [NCBI, ExPASy, EBI, Israel, Japan]
Zemmour J.,
Little A.-M.,
Schendel D.J.,
Parham P.;
"The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.";
J. Immunol. 148:1941-1948(1992).
|
[4]
|
NUCLEOTIDE SEQUENCE (ALLELE B*3503).
TISSUE=Blood;
DOI=10.1084/jem.181.6.2037; PubMed=7759996 [NCBI, ExPASy, EBI, Israel, Japan]
Beck Y.,
Satz L.,
Takamiya Y.,
Nakayama S.,
Ling L.,
Ishikawa Y.,
Nagao T.,
Uchida H.,
Tokunaga K.,
Mueller C.,
Juji T.,
Takiguchi M.;
"Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.";
J. Exp. Med. 181:2037-2048(1995).
|
[5]
|
NUCLEOTIDE SEQUENCE (ALLELES B*3505 AND B*3506).
DOI=10.1038/357326a0; PubMed=1317015 [NCBI, ExPASy, EBI, Israel, Japan]
Belich M.P.,
Madrigal J.A.,
Hildebrand W.H.,
Zemmour J.,
Williams R.C.,
Luz R.,
Petzl-Erler M.L.,
Parham P.;
"Unusual HLA-B alleles in two tribes of Brazilian Indians.";
Nature 357:326-329(1992).
|
[6]
|
NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*3507 AND B*3508).
PubMed=8316945 [NCBI, ExPASy, EBI, Israel, Japan]
Theiler G.,
Pando M.,
Delfino J.M.,
Takiguchi M.,
Satz M.L.;
"Isolation and characterization of two new functional subtypes of HLA-B35.";
Tissue Antigens 41:143-147(1993).
|
[7]
|
NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*3508).
DOI=10.1016/0198-8859(93)90553-D; PubMed=8138421 [NCBI, ExPASy, EBI, Israel, Japan]
Steinle A.,
Reinhardt C.,
Noessner E.,
Uchanska-Ziegler B.,
Ziegler A.,
Schendel D.J.;
"Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody.";
Hum. Immunol. 38:261-269(1993).
|
[8]
|
NUCLEOTIDE SEQUENCE OF 9-362 (ALLELE B*3504).
DOI=10.1038/357329a0; PubMed=1589035 [NCBI, ExPASy, EBI, Israel, Japan]
Watkins D.I.,
McAdam S.N.,
Liu X.,
Stang C.R.,
Milford E.L.,
Levine C.G.,
Garber T.L.,
Dogon A.L.,
Lord C.I.,
Ghim S.H.,
Troup G.M.,
Hughes A.L.,
Letvin N.L.;
"New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci.";
Nature 357:329-333(1992).
|
[9]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*3529 AND B*3532).
DOI=10.1034/j.1399-0039.2000.550311.x; PubMed=10777103 [NCBI, ExPASy, EBI, Israel, Japan]
Kennedy C.T.,
Dodd R.,
Le T.,
Wallace R.,
Ng G.,
Greville W.D.,
Kennedy A.,
Taverniti A.,
Moses J.H.,
Clow N.,
Watson N.,
Dunckley H.;
"Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529, B*3532, B*4025, B*5304 and B*5508.";
Tissue Antigens 55:266-270(2000).
|
[10]
|
NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES B*3525; B*3528; B*3529; B*3530 AND B*3536).
DOI=10.1034/j.1399-0039.2001.057005481.x; PubMed=11556976 [NCBI, ExPASy, EBI, Israel, Japan]
Steiner N.K.,
Kosman C.,
Jones P.F.,
Gans C.P.,
Rodriguez-Marino S.G.,
Rizzuto G.,
Baldassarre L.A.,
Edson S.,
Koester R.,
Sese D.,
Mitton W.,
Ng J.,
Hartzman R.J.,
Hurley C.K.;
"Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG.";
Tissue Antigens 57:481-485(2001).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 25-300.
DOI=10.1016/S1074-7613(00)80429-X; PubMed=8624811 [NCBI, ExPASy, EBI, Israel, Japan]
Smith K.J.,
Reid S.W.,
Stuart D.I.,
McMichael A.J.,
Jones E.Y.,
Bell J.I.;
"An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.";
Immunity 4:203-214(1996).
|
[12]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
DOI=10.1006/jmbi.1998.2363; PubMed=9878435 [NCBI, ExPASy, EBI, Israel, Japan]
Menssen R.,
Orth P.,
Ziegler A.,
Saenger W.;
"Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C-terminus.";
J. Mol. Biol. 285:645-653(1999).
|
|
ExPASy Home page
APAF Australia
